Randomized, Open-Label Study of the Pharmacokinetics and Safety of Oral and Intravenous Administration of Omadacycline to Healthy Subjects

@inproceedings{Sun2016RandomizedOS,
  title={Randomized, Open-Label Study of the Pharmacokinetics and Safety of Oral and Intravenous Administration of Omadacycline to Healthy Subjects},
  author={Haiying Sun and Lillian S. L. Ting and Surendra Machineni and Jens Praestgaard and Andreas Kuemmell and Daniel S. Stein and Gangadhar Sunkara and Steven J. Kovacs and Stephen A. Villano and S. Ken Tanaka},
  booktitle={Antimicrobial agents and chemotherapy},
  year={2016}
}
  • Haiying Sun, Lillian S. L. Ting, +7 authors S. Ken Tanaka
  • Published in
    Antimicrobial agents and…
    2016
  • Medicine
  • Omadacycline is a first-in-class aminomethylcycline antibiotic with microbiological activity against Gram-positive and Gram-negative aerobes and anaerobes and atypical bacteria that is being developed for the treatment of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP). The bioavailability of a phase 3 tablet formulation relative to that obtained via intravenous (i.v.) administration (and of other oral formulations relative to that… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    1
    Twitter Mention

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 15 CITATIONS

    Omadacycline: A New Tetracycline Antibiotic

    VIEW 4 EXCERPTS
    CITES BACKGROUND
    HIGHLY INFLUENCED

    Pharmacokinetics and Pharmacodynamics of Oral and Intravenous Omadacycline

    VIEW 4 EXCERPTS
    CITES METHODS & BACKGROUND
    HIGHLY INFLUENCED

    An Integrated Safety Summary of Omadacycline, a Novel Aminomethylcycline Antibiotic

    VIEW 1 EXCERPT
    CITES BACKGROUND

    Omadacycline: A Modernized Tetracycline

    • Jason C Gallagher
    • Medicine
    • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
    • 2019

    Omadacycline: a novel aminomethylcycline

    VIEW 2 EXCERPTS
    CITES METHODS & BACKGROUND

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 14 REFERENCES

    Pharmacokinetics of intravenous and oral PTK796, a new aminomethylcycline antibiotic, abstr K-124

    • L Ting, H Sun, SJ Kovacs, K Klausner, SK. Tanaka
    • Abstr 50th Intersci Conf Antimicrob Agents Chemother
    • 2010
    VIEW 4 EXCERPTS
    HIGHLY INFLUENTIAL

    In vitro and in vivo assessment of cardiovascular effects with omadacycline. Antimicrob Agents Chemother http://dx.doi.org/10.1128/AAC.00320-16

    • S Villano, SK Tanaka
    • 2016
    VIEW 2 EXCERPTS

    Mechanism of action of the novel aminomethylcycline antibiotic omadacycline.

    VIEW 1 EXCERPT

    Pharmacokinetics of [14C]-labelled omadacycline (PTK 0796) in healthy male subjects, abstr A-1281

    • H Sun, L Ting, +6 authors SK. Tanaka
    • Abstr 52nd Intersci Conf Antimicrob Agents Chemother
    • 2012
    VIEW 1 EXCERPT

    Broad-spectrum fluorocycline TP-434 has oral bioavailability in human, abstr P-1509

    • A Leighton, I Zupanets, +3 authors JA. Sutcliffe
    • Abstr 21st Eur Congr Clin Microbiol Infect Dis
    • 2011
    VIEW 1 EXCERPT

    In vitro evaluation of PTK796 activity tested against Staphylococcus aureus, including hospital- and community-associated MRSA strains from the USA and Europe, abstr E-1569

    • DJ Biedenbach, RE Mendes, HS Sader, RN. Jones
    • Abstr 50th Intersci Conf Antimicrob Agents Chemother
    • 2010